- The Nasdaq has granted Aytu BioPharma (NASDAQ:AYTU) a 180-day extension to regain compliance with the stock exchange's minimum bid price requirement.
- AYTU now has until May 22, 2023, to regain compliance.
- The compliance will be regained if at any time until May 22, 2023, the bid price per share closes at or above $1.00 for a minimum of 10 consecutive trading days.
- If the company does not comply with the minimum bid price requirement during the 180-day grace period than its shares are subject to delisting.
- AYTU shares were trading +4.31% after-hours.